Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Philip

Showing results (441-450 of 521) with videos related to

Pageof 53
Sort By:
Annals of Surgery|August 3, 2020
Surgical Outcome Results From SWOG S1505: A Randomized Clinical Trial of mFOLFIRINOX Versus Gemcitabine/Nab-paclitaxel for Perioperative Treatment of Resectable Pancreatic Ductal AdenocarcinomaSyed A Ahmad, Mai Duong, Davendra P S Sohal, et al.
Biorxiv : the Preprint Server for Biology|December 3, 2025
Neural mechanisms of handedness for precision drawing: hand-dependent engagement of cortical networks for bimanual control and tool useN Kapil, T Kim, S Gassass, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 10, 2010
Report of a multicenter phase II trial testing a combination of biweekly bevacizumab and daily erlotinib in patients with unresectable biliary cancer: a phase II Consortium studySam J Lubner, Michelle R Mahoney, Jill L Kolesar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 14, 2019
Preclinical Assessment with Clinical Validation of Selinexor with Gemcitabine and Nab-Paclitaxel for the Treatment of Pancreatic Ductal AdenocarcinomaAsfar S Azmi, Husain Yar Khan, Irfana Muqbil, et al.
Targeted Oncology|March 27, 2025
A Phase 1b/2 Study of the Anti-CD47 Antibody Magrolimab with Cetuximab in Patients with Colorectal Cancer and Other Solid TumorsCathy Eng, Nehal J Lakhani, Philip A Philip, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2026
METTL14-dependent m <sup>6</sup> A modification restrains interferon signaling to prevent myocarditis and dilated CardiomyopathyYu Xi, Jacob Kuempel, Sukwon Choi, et al.
Journal of Gastrointestinal Oncology|November 18, 2021
Molecular characterization of squamous cell carcinoma of the anal canalSamantha A Armstrong, Rita Malley, Hongkun Wang, et al.
Cancers|April 3, 2020
Calcium Release-Activated Calcium (CRAC) Channel Inhibition Suppresses Pancreatic Ductal Adenocarcinoma Cell Proliferation and Patient-Derived Tumor GrowthHusain Yar Khan, Gabriel B Mpilla, Rachel Sexton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 8, 2010
Pain and emotional well-being outcomes in Southwest Oncology Group-directed intergroup trial S0205: a phase III study comparing gemcitabine plus cetuximab versus gemcitabine as first-line therapy in patients with advanced pancreas cancerCarol M Moinpour, Nancy L Vaught, Bryan Goldman, et al.
International Journal of Nanomedicine|February 19, 2019
<sup>99m</sup>Tc-radiolabeled composites enabling in vivo imaging of arterial dispersal and retention of microspheres in the vascular network of rabbit lungs, liver, and liver tumorsRoss W Stephens, Gregory D Tredwell, Karen J Knox, et al.
Pageof 53

Showing results (441-450 of 521) with videos related to

Sort By:
Pageof 53
Annals of Surgery|August 3, 2020
Surgical Outcome Results From SWOG S1505: A Randomized Clinical Trial of mFOLFIRINOX Versus Gemcitabine/Nab-paclitaxel for Perioperative Treatment of Resectable Pancreatic Ductal AdenocarcinomaSyed A Ahmad, Mai Duong, Davendra P S Sohal, et al.
Biorxiv : the Preprint Server for Biology|December 3, 2025
Neural mechanisms of handedness for precision drawing: hand-dependent engagement of cortical networks for bimanual control and tool useN Kapil, T Kim, S Gassass, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 10, 2010
Report of a multicenter phase II trial testing a combination of biweekly bevacizumab and daily erlotinib in patients with unresectable biliary cancer: a phase II Consortium studySam J Lubner, Michelle R Mahoney, Jill L Kolesar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 14, 2019
Preclinical Assessment with Clinical Validation of Selinexor with Gemcitabine and Nab-Paclitaxel for the Treatment of Pancreatic Ductal AdenocarcinomaAsfar S Azmi, Husain Yar Khan, Irfana Muqbil, et al.
Targeted Oncology|March 27, 2025
A Phase 1b/2 Study of the Anti-CD47 Antibody Magrolimab with Cetuximab in Patients with Colorectal Cancer and Other Solid TumorsCathy Eng, Nehal J Lakhani, Philip A Philip, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2026
METTL14-dependent m <sup>6</sup> A modification restrains interferon signaling to prevent myocarditis and dilated CardiomyopathyYu Xi, Jacob Kuempel, Sukwon Choi, et al.
Journal of Gastrointestinal Oncology|November 18, 2021
Molecular characterization of squamous cell carcinoma of the anal canalSamantha A Armstrong, Rita Malley, Hongkun Wang, et al.
Cancers|April 3, 2020
Calcium Release-Activated Calcium (CRAC) Channel Inhibition Suppresses Pancreatic Ductal Adenocarcinoma Cell Proliferation and Patient-Derived Tumor GrowthHusain Yar Khan, Gabriel B Mpilla, Rachel Sexton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 8, 2010
Pain and emotional well-being outcomes in Southwest Oncology Group-directed intergroup trial S0205: a phase III study comparing gemcitabine plus cetuximab versus gemcitabine as first-line therapy in patients with advanced pancreas cancerCarol M Moinpour, Nancy L Vaught, Bryan Goldman, et al.
International Journal of Nanomedicine|February 19, 2019
<sup>99m</sup>Tc-radiolabeled composites enabling in vivo imaging of arterial dispersal and retention of microspheres in the vascular network of rabbit lungs, liver, and liver tumorsRoss W Stephens, Gregory D Tredwell, Karen J Knox, et al.
Pageof 53